Type

Endospan, an innovative Israeli-based Aortic Arch medical device company, secures a $25 million financing from CryoLife [NYSE:CRY].

Clipperton acted as sole financial advisor to Endospan.

This transaction highlights Clipperton expertise in cross-border transactions after a series of completed deals within the last 12 months – e.g. NetRange (DE) /Access Co (JP), Musement (IT) / TUI (DE), Vide Dressing (FR) /Adevinta (NO), Givve (DE) / Up Group (FR), Matooma (FR) / Wireless Logic Group (UK).